EUDAW Market Analysis

Overview

Fundamentals

P/E ratio
EPS (TTM)0.0% YoY
Profit margin5.2%
Market cap

Valuation

Forward P/E
PEG ratio
P/B
P/S (TTM)
EV/EBITDA

Profitability & growth

ROE (TTM)
0.0%
Operating margin
-37.0%
Revenue growth YoY
60.2%
Dividend yield
Beta
0.16

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

About EUDA Health Holdings Limited

EUDA Health Holdings Limited is a dynamic biotechnology firm committed to developing cutting-edge therapies targeting dermatological and chronic health conditions. The company emphasizes scientific excellence and the integration of advanced technologies to address critical unmet medical needs, supported by a strategically prioritized pipeline of innovative products. With a seasoned leadership team focused on enhancing patient outcomes, EUDA is well-positioned to capitalize on growth opportunities in the evolving healthcare landscape.

Classification

Exchange
NASDAQ
Country
USA
Currency
USD

Company profile

HQ
60 KAKI BUKIT PLACE, SINGAPORE, SINGAPORE
Fiscal year end
December
Latest quarter
Sep 30, 2025
Shares outstanding$0
52W high$0.18
52W low$0.02

Educational content · Not investment advice or recommendations

We're educators, not advisors. Your decisions are your own. Disclaimer